Literature DB >> 16741955

Cdk9 phosphorylates p53 on serine 392 independently of CKII.

Pier Paolo Claudio1, Jianqi Cui, Mohammad Ghafouri, Chiara Mariano, Martyn K White, Mahmut Safak, Joel B Sheffield, Antonio Giordano, Kamel Khalili, Shohreh Amini, Bassel E Sawaya.   

Abstract

The tumor suppressor p53 is an important cellular protein, which controls cell cycle progression. Phosphorylation is one of the mechanisms by which p53 is regulated. Here we report the interaction of p53 with another key regulator, cdk9, which together with cyclin T1 forms the positive transcription elongation complex, p-TEFb. This complex cooperates with the HIV-1 Tat protein to cause the phosphorylation of the carboxyl terminal domain (CTD) of RNA polymerase II and this facilitates the elongation of HIV-1 transcription. We demonstrate that cdk9 phosphorylates p53 on serine 392 through their direct physical interaction. Results from protein-protein interaction assays revealed that cdk9 interacts with the C-terminal domain (aa 361-393) of p53, while p53 interacts with the N-terminal domain of cdk9. Transfection and protein binding assays (EMSA and ChIP) demonstrated the ability of p53 to bind and activate the cdk9 promoter. Interestingly, cdk9 phosphorylates serine 392 of p53, which could be also phosphorylated by casein kinase II. Kinase assays demonstrated that cdk9 phosphorylates p53 independently of CKII. These studies demonstrate the existence of a feedback-loop between p53 and cdk9, pinpointing a novel mechanism by which p53 regulates the basal transcriptional machinery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16741955     DOI: 10.1002/jcp.20698

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  22 in total

1.  Transcriptional regulation of HIV-1 gene expression by p53.

Authors:  Ruma Mukerjee; Pier Paolo Claudio; J Robert Chang; Luis Del Valle; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2010-11-15       Impact factor: 4.534

2.  Kaposi's sarcoma-associated herpesvirus K-cyclin interacts with Cdk9 and stimulates Cdk9-mediated phosphorylation of p53 tumor suppressor.

Authors:  Pei-Ching Chang; Mengtao Li
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

3.  Research highlights on a notable retrovirus and a popular guardian gene.

Authors:  Paraskevi Vogiatzi; Philip J Mason
Journal:  Cell Cycle       Date:  2010-12-15       Impact factor: 4.534

Review 4.  Transcriptional regulation by p53.

Authors:  Rachel Beckerman; Carol Prives
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-04-28       Impact factor: 10.005

Review 5.  Induction and activation of the p53 pathway: a role for the protein kinase CK2?

Authors:  David W Meek; Miranda Cox
Journal:  Mol Cell Biochem       Date:  2011-07-19       Impact factor: 3.396

Review 6.  Role of p53 in neurodegenerative diseases.

Authors:  J Robert Chang; Mohammad Ghafouri; Ruma Mukerjee; Asen Bagashev; Tinatin Chabrashvili; Bassel E Sawaya
Journal:  Neurodegener Dis       Date:  2011-10-28       Impact factor: 2.977

7.  Serine 392 phosphorylation modulates p53 mitochondrial translocation and transcription-independent apoptosis.

Authors:  Cédric Castrogiovanni; Béranger Waterschoot; Olivier De Backer; Patrick Dumont
Journal:  Cell Death Differ       Date:  2017-09-22       Impact factor: 15.828

8.  Phospho switch triggers Brd4 chromatin binding and activator recruitment for gene-specific targeting.

Authors:  Shwu-Yuan Wu; A-Young Lee; Hsien-Tsung Lai; Hong Zhang; Cheng-Ming Chiang
Journal:  Mol Cell       Date:  2013-01-11       Impact factor: 17.970

9.  Cdk9 phosphorylates Pirh2 protein and prevents degradation of p53 protein.

Authors:  Asen Bagashev; Shongshan Fan; Ruma Mukerjee; Pier Paolo Claudio; Tinatin Chabrashvili; Roger P Leng; Samuel Benchimol; Bassel E Sawaya
Journal:  Cell Cycle       Date:  2013-04-19       Impact factor: 4.534

10.  P-TEFb- the final frontier.

Authors:  Jiri Kohoutek
Journal:  Cell Div       Date:  2009-09-02       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.